Together We Are Stronger: Eurice Endorses European Commission’s Manifesto for EU COVID-19 Research
In July 2020, the European Commission launched a manifesto looking to support the accessibility of research results in the fight against COVID-19. So far, the manifesto boasts more than 2,000 signatories from public and private stakeholders as well as from prominent individuals and institutions from all over Europe and beyond.
Eurice is proud to join this important cause which is providing the guiding principles for beneficiaries of EU research grants to make the generated results on coronavirus prevention, testing, treatment and vaccination public available immediately and accessible to all.
In detail, the key pillars of the manifesto include:
Make the generated results, whether tangible or intangible, public and accessible without delay, for instance on the Horizon Results Platform, on an existing IP sharing platform, or through an existing patent pool.
Make scientific papers and research data available in open access without delay and following the FAIR principles via preprint servers or public repositories, with rights for others to build upon the publications and data and with access to the tools needed for their validation. In particular, make COVID-19 research data available through the European COVID-19 Data Platform.
Where possible, grant for a limited time, non-exclusive royalty free licences on the intellectual property resulting from EU-funded research. These non-exclusive royalty free licenses shall be given in exchange for the licensees’ commitment to rapidly and broadly distribute the resulting products and services under fair and reasonable conditions to prevent, diagnose, treat and contain COVID-19.
Jörg Scherer, CEO of Eurice says: “This manifesto is an important step towards a better valorisation of research results. If this pandemic has shown us anything, it’s how important research across European borders and its funding is. We wholeheartedly support the message of the European Commission’s Manifesto for EU COVID-19 Research.”